Assessment of nephrotoxicity in patients receiving amphotericin B lipid complex: a pharmacosurveillance study in Spain J.-M. Aguado, C. Lumbreras, D. González-Vidal Clinical Microbiology and Infection Volume 10, Issue 9, Pages 785-790 (September 2004) DOI: 10.1111/j.1198-743X.2004.00963.x Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 1 Median serum creatinine concentration change following treatment with amphotericin B lipid complex in the overall study population. Clinical Microbiology and Infection 2004 10, 785-790DOI: (10.1111/j.1198-743X.2004.00963.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions
FIG. 2 Median serum creatinine concentration change following treatment with amphotericin B lipid complex for patients with baseline creatinine values ≥2 mg/dL. Clinical Microbiology and Infection 2004 10, 785-790DOI: (10.1111/j.1198-743X.2004.00963.x) Copyright © 2004 European Society of Clinical Infectious Diseases Terms and Conditions